Funding Rounds
SciRhom

SciRhom Series A (2024, $68M)

SciRhom

iRhom2 antibodies developer for better treatment of autoimmune diseases.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $68.25M

Raised Date: 2024-09-01